
Gradient Health is a medical technology company focused on accelerating AI development in healthcare by providing access to millions of de-identified medical images. They cater to AI developers who need large, diverse datasets to train and validate their algorithms, enabling faster regulatory clearance and product launch. For hospitals and health systems, Gradient Health offers a data partnership program, allowing them to contribute their data for research and receive a share of the revenue. Their platform emphasizes responsibly sourced, machine learning-ready data, searchable by modality and disease type, with key features including de-identification, diversity, and scale. Their product suite includes Atlas, Atlas+, and Atlas Concierge, offering self-service and fully outsourced data sourcing solutions.

Gradient Health is a medical technology company focused on accelerating AI development in healthcare by providing access to millions of de-identified medical images. They cater to AI developers who need large, diverse datasets to train and validate their algorithms, enabling faster regulatory clearance and product launch. For hospitals and health systems, Gradient Health offers a data partnership program, allowing them to contribute their data for research and receive a share of the revenue. Their platform emphasizes responsibly sourced, machine learning-ready data, searchable by modality and disease type, with key features including de-identification, diversity, and scale. Their product suite includes Atlas, Atlas+, and Atlas Concierge, offering self-service and fully outsourced data sourcing solutions.
What they do: Provide access to millions of de-identified medical imaging studies for AI development via the Atlas platform
Headquarters: Durham, North Carolina, United States
Founders / leadership: Joshua (Josh) Miller; Ouwen Huang; Suyash Kumar (listed as founder)
Employees: 38
Total funding (reported): USD 5,700,000
Latest round: Seed, closed Jun 20, 2023 (lead: ReMY Investors & Consultants)
Medical imaging data access and tooling for AI model development and validation
Medical technology / Healthcare AI
Latest disclosed round
“Has backing from a set of seed-stage investors including ReMY Investors & Consultants and multiple other participants reported across rounds”